Mitchell McLeod Pugh & Williams’s Allergan Inc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,982
| Closed | -$705K | – | 190 |
|
|
2020
Q1 | $705K | Hold |
3,982
| – | – | 0.54% | 62 |
|
|
2019
Q4 | $761K | Hold |
3,982
| – | – | 0.48% | 70 |
|
|
2019
Q3 | $670K | Hold |
3,982
| – | – | 0.45% | 75 |
|
|
2019
Q2 | $667K | Sell |
3,982
-418
| -10% | -$70K | 0.46% | 80 |
|
|
2019
Q1 | $644K | Buy |
4,400
+615
| +16% | +$90K | 0.45% | 83 |
|
|
2018
Q4 | $506K | Sell |
3,785
-70
| -2% | -$9.36K | 0.41% | 89 |
|
|
2018
Q3 | $734K | Sell |
3,855
-80
| -2% | -$15.2K | 0.49% | 68 |
|
|
2018
Q2 | $656K | Sell |
3,935
-30
| -0.8% | -$5K | 0.46% | 80 |
|
|
2018
Q1 | $667K | Hold |
3,965
| – | – | 0.48% | 77 |
|
|
2017
Q4 | $649K | Sell |
3,965
-10
| -0.3% | -$1.64K | 0.45% | 83 |
|
|
2017
Q3 | $815K | Hold |
3,975
| – | – | 0.6% | 62 |
|
|
2017
Q2 | $966K | Hold |
3,975
| – | – | 0.73% | 45 |
|
|
2017
Q1 | $950K | Hold |
3,975
| – | – | 0.74% | 43 |
|
|
2016
Q4 | $835K | Hold |
3,975
| – | – | 0.68% | 51 |
|
|
2016
Q3 | $915K | Hold |
3,975
| – | – | 0.8% | 41 |
|
|
2016
Q2 | $919K | Hold |
3,975
| – | – | 0.83% | 40 |
|
|
2016
Q1 | $1.06M | Hold |
3,975
| – | – | 1.03% | 28 |
|
|
2015
Q4 | $1.24M | Sell |
3,975
-200
| -5% | -$62.5K | 1.23% | 17 |
|
|
2015
Q3 | $1.13M | Hold |
4,175
| – | – | 1.17% | 19 |
|
|
2015
Q2 | $1.27M | Buy |
+4,175
| New | +$1.27M | 1.17% | 20 |
|
Mitchell McLeod Pugh & Williams's AGN Position: Q2 2020 in Review
Mitchell McLeod Pugh & Williams sold out of Allergan Inc (AGN) in Q2 2020, closing a stake of 3,982 shares — an estimated $705K sold.
Mitchell McLeod Pugh & Williams first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $1.27M in Q2 2015. 0 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Mitchell McLeod Pugh & Williams reported no remaining Allergan Inc position as of Q2 2020 after selling out during the quarter.
- Mitchell McLeod Pugh & Williams sold 3,982 Allergan Inc shares in Q2 2020, an estimated $705K.
- Mitchell McLeod Pugh & Williams first reported a position in Allergan Inc in Q2 2015 and held it in 20 quarters.
- Mitchell McLeod Pugh & Williams's Allergan Inc position peaked at $1.27M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2020.
Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2020, filed 17 Jul 2020.